Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TADALAFIL vs TAFASITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TADALAFIL vs TAFASITAMAB: Safety Overview

Metric TADALAFIL TAFASITAMAB
Total FAERS Reports 30,683 1,392
Deaths Reported 3,553 475
Death Rate 11.6% 34.1%
Hospitalizations 8,717 433
Average Patient Age 58.7 yrs 70.0 yrs
% Female Patients 42.7% 50.1%
FDA Approval Date Apr 29, 2019 N/A
Manufacturer Guangzhou Yixin Cross-border E-commer... Incyte Corporation
Route TOPICAL INTRAVENOUS
Marketing Status Prescription N/A